P. D. Weyker, C. A. Webb, D. Kiamanesh, and B. C. Flynn, "Lung ischemia reperfusion injury: a bench-to-bedside review," Seminars in Cardiothoracic and Vascular Anesthesia, vol. 17, no. 1, pp. 28-43, 2013.
 J. M. Diamond, J. C. Lee, S. M. Kawut et al., "Clinical risk factors for primary graft dysfunction after lung transplantation," American Journal of Respiratory and Critical Care Medicine, vol. 187, no. 5, pp. 527-534, 2013.
 M. de Perrot, M. Liu, T. K. Waddell, and S. Keshavjee, "Ischemia-reperfusion-induced lung injury," American Journal of Respiratory and Critical Care Medicine, vol. 167, no. 4, pp. 490-511, 2003.
 A. Prakash, S. V. Sundar, Y. G. Zhu et al., "Lung ischemia-reperfusion is a sterile inflammatory process influenced by commensal microbiota in mice," Shock, vol. 44, no. 3, pp. 272-279, 2015.
 R. C. Silva, M. A. Landgraf, M. Corrêa-Costa et al., "Acute kidney injury reduces phagocytic and microbicidal capacities ofalveolar macrophages," cellular physiology and biochemistry, vol. 31, no. 2, pp. 179-188, 2013.
 S. Chiu, and A. Bharat, " Role of monocytes andmacrophagesin regulatingimmuneresponsefollowinglung transplantation," Current opinion in organ transplantation, vol. 21, no. 3, pp. 239-245, 2016.
 Z. Lanyu, H. Feilong. "Emerging role of extracellular vesicles inlung injuryand inflammation," biomedicine & pharmacotherapy, vol.113, Article ID 108748, 2019.
 F. Lin, J. F. Feng, T. T. Wang et al., "Glycyrrhizin ameliorate ischemia reperfusion lung injury through downregulate TLR2 signaling cascade in alveolar macrophages. Frontiers in Pharmacology, vol. 8, Article ID 389, 2017.
 S. Grootjans, B. T. Vanden, and P. Vandenabeele, "Initiation and execution mechanisms of necroptosis: an overview," Cell Death and Differentiation, vol. 24, no. 7, pp.1184-1195, 2017.
 N. Kayagaki, I. B. Stowe, B. L. Lee et al., "Caspase-11 cleaves gasdermin D for non-canonical inﬂammasome signalling," Nature, vol. 526, no. 7575, pp. 666-671, 2015.
 J. Shi, Y. Zhao, K.Wang et al., "Cleavage of GSDMD by inﬂammatory caspases determines pyroptotic cell death," Nature, vol. 526, no. 7575, pp. 660-665, 2015.
 J. Ding, K.Wang, W. Liu et al., "Pore-forming activity and structural autoinhibition of the gasdermin family," Nature, vol. 535, no. 7610, pp. 111-116, 2016.
 S. Toldo, A. G. Mauro, Z. S. Cutter and A. Abbate, "Inflammasome,pyroptosis, and cytokines in myocardialischemia-reperfusioninjury," American Journal of Physiology-Heart and Circulatory Physiology, vol. 315, no. 6, pp. H1553-H1568, 2018.
 H. Zhao, H. Huang, A. Alam et al., "VEGF mitigates histone-inducedpyroptosisin the remote liver injury associated with renal allograftischemia-reperfusioninjury in rats," American Journal of Transplantation, vol. 18, no. 8, pp. 1890-1903, 2018.
 H. Yang, H. S. Hreggvidsdottir, K. Palmblad et al., "A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 andactivation of macrophage cytokine release," Proceedings of the National Academy of Sciences of the United States of America , vol. 107, no. 26, pp. 11942-11947, 2010.
 J. Zhang, Y. Wu, Z. Weng et al., "Glycyrrhizin protects brain against ischemia–reperfusion injury in mice through HMGB1-TLR4-IL-17A signaling pathway," Brain research, vol. 1582, pp. 176-186, 2014.
 X. Hu, H. Jiang, B. Cui et al., "Preconditioning with high mobility group box 1 protein protects against myocardial ischemia-reperfusion injury," International Journal of Cardiology, vol. 145, no. 1, pp. 111-112, 2010.
 H. Wu, R. Steenstra, E. C. de Boer et al., "Preconditioning with recombinant high-mobility group box 1 protein protects the kidney against ischemia-reperfusion injury in mice," Kidney International, vol. 85, no. 4, pp. 824-832, 2014.
 C. Wang, X.X Liu, K. B. Huang et al., "Preconditioning with recombinant high-mobility group box 1 induces ischemic tolerance in a rat model of focal cerebral ischemia-reperfusion. Journal of Neurochemistry, vol. 137, no. 4, pp. 576-588, 2016.
 M. S. Seo, H. J. Kim, H. Kim and S. W. Park, "Ethyl Pyruvate Directly Attenuates Active Secretion of HMGB1 in Proximal Tubular Cells via Induction of Heme Oxygenase-1," Journal of Clinical Medicine, vol. 8, no. 5, Article ID pii:E629, 2019.
 Z. Sun, F. Wang, Y. Yang et al., "Resolvin D1 attenuates ventilator-induced lung injury by reducing HMGB1 release in a HO-1-dependent pathway," International Immunopharmacology, vol. 75, Article ID 105825, 2019.
 Q. Sun, Y. Wu, F. Zhao and J.Wang, "Maresin 1 Ameliorates Lung Ischemia/Reperfusion Injury by Suppressing Oxidative Stress via Activation of the Nrf-2-Mediated HO-1 Signaling Pathway," Oxidative Medicine and Cellular Longevity, vol. 2017, Article ID 9634803, 2017.
 M. Saito, T. F. Chen-Yoshikawa, M. Takahashi et al., "Protective effects of a hydrogen-rich solution during cold ischemia in rat lung transplantation," The Journal of Thoracic and Cardiovascular Surgery, vol. pii: S0022-5223, no. 19, pp. 32355-4, 2019.
 J. Luo, X. Li, X. Li et al., "Selenium-Rich Yeast protects against aluminum-induced peroxidation of lipide and inflammation in mice liver," Biometals, vol. 31, no. 6, pp. 1051-1059, 2018.
 C. Diao, Z. Chen, T. Qiu et al., "Inhibition of PRMT5 Attenuates Oxidative Stress-Induced Pyroptosis via Activation of the Nrf2/HO-1 Signal Pathway in a Mouse Model of Renal Ischemia-Reperfusion Injury," Oxidative Medicine and Cellular Longevity, vol. 2019, Article ID 2345658, 2019.
 X. Han, W. Yao, Z. Liu et al., "Lipoxin A4 Preconditioning Attenuates Intestinal Ischemia Reperfusion Injury through Keap1/Nrf2 Pathway in a Lipoxin A4 Receptor Independent Manner," Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 9303606, 2016.
 F. Lin, L. H. Pan, L. Ruan et al., "Differential expression of HIF-1alpha, AQP-1, and VEGF under acute hypoxic conditions in the non-ventilated lung of a one-lung ventilation rat model," Life Sciences, vol. 124, pp. 50-55, 2015.
 H. Dai, L. Pan, F. Lin et al., "Mechanical ventilation modulates Toll-like receptors 2, 4, and 9 on alveolar macrophages in a ventilator-induced lung injury model," Journal of Thoracic Disease, vol. 7, no. 4, pp. 616-624, 2015.
 F. Song, J. Hou, Z. Chen et al., "Sphingosine-1-phosphate Receptor 2 Signaling Promotes Caspase-11–dependent Macrophage Pyroptosis and Worsens Escherichia coli Sepsis Outcome," Anesthesiology, vol. 129, no. 2, pp. 311-320, 2018.
 M. T. Lotze, and K. J. Tracey, "High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal," Nature Reviews Immunology, vol. 5, no. 4, pp. 331-342, 2005.
 J. R. Klune, T. R. Billiar, and A. Tsung, "HMGB1 preconditioning: therapeutic application for a danger signal?" Journal of Leukocyte Biology, vol. 83, no. 3, pp. 558-563, 2008.
 R. S. Ferrari and C. F. Andrade, “Oxidative stress and lung ischemia-reperfusion injury,” Oxidative Medicine and Cellular Longevity, vol. 2015, Article ID 590987, 2015.
 S. Wang, C. Wang, F. Yan et al., “N-acetylcysteine attenuates diabetic myocardial ischemia reperfusion injury through inhibiting excessive autophagy,” Mediators of Inflammation, vol. 2017, Article ID 9257291, 2017.
 D. Y. Yeh, S. P. Tung, Y. H. Fu et al., “Intravenous superoxide dismutase administration reduces contralateral lung injury induced by unilateral lung ischemia and reperfusion in rats through suppression of activity and protein expression of matrix metalloproteases,” Transplantation Proceedings, vol. 47, no. 4, pp. 1083–1086, 2015.
 M. Ge, X. Chi, A. Zhang et al., “Intestinal NF-E2-related factor-2 expression and antioxidant activity changes in rats undergoing orthotopic liver autotransplantation," Oncology Letters, vol. 6, no. 5, pp. 1307-1312, 2013.
 T. Nguyen, P. Nioi, C. B. Pickett, "The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress," Journal of Biological Chemistry, vol. 284, no. 20, pp. 13291-13295, 2009.
 M. A. O'Connell, J. D. Hayes, "The Keap1/Nrf2 pathway in health and disease: from the bench to the clinic," Biochemical Society Transactions, vol. 43, no. 4, pp. 687-689, 2015.